openPR Logo
Press release

COPD and Asthma Devices Market: High-end Analysis of the Key Segments with Leading Manufacturers like Novartis AG, Merck & Co., Inc., AstraZeneca Plc, Philips Healthcare and 3M Health Care

02-18-2019 04:08 PM CET | Health & Medicine

Press release from: Allied Market

COPD and Asthma Devices Market: High-end Analysis of the Key

Global COPD and asthma devices market is expected to reach $41,355.2 million by 2022, according to a new report by Allied Market Research . The drug powder inhaler was the highest revenue-generating segment, accounting for over half of the share in 2015. This segment is expected to maintain its dominance throughout the forecast period.

Compressor nebulizers constitute around four-fifths share of the overall nebulizers market, owing to their perpetual usage in home healthcare medication and widespread availability across various regions. Nebulizers are electric- or battery-powered machines, which dispense the medication in the form of fine mist. They are used in home healthcare set-ups for debilitated patients, geriatric, and children. However, the large size of nebulizers.

The factors hampering the market growth include environmental concerns associated with metered dose inhalers (MDI) and high cost of selected inhalation devices. Regulatory authorities such as U.S. food and drug administration (USFDA) across several regions have banned the production and sales of MDIs, as they release environmentally hazardous gases such as chlorofluorocarbon (CFC) and hydrofluoroalkanes (HFA). Thus, soft mist inhalers (SMIs) and nebulizers are expected to replace MDIs for the treatment of respiratory diseases in the near future.

Get sample copy of this report at:
www.alliedmarketresearch.com/request-sample/579?utm_source=PC_OPR

North America is expected to remain the highest revenue-generating region, owing to widespread and early adoption of inhalers & nebulizers and large pool of patients suffering from respiratory diseases. Moreover, the Asia-Pacific region is expected to grow rapidly due to rising healthcare expenditure, growing awareness of advanced portable COPD & asthma devices, and increasing disposable income.

Key players:

• GlaxoSmithKline Plc
• Novartis AG
• Merck & Co.Inc.
• AstraZeneca Plc
• Philips Healthcare
• 3M Health Care
• Allied Healthcare ProductsInc.
• Sunovion Pharmaceuticals Inc.
• GF Healthcare Products
• Smith Medicals Inc.
• Lincare Holdings Inc.
• Baxter International.

Key findings of COPD and Asthma Devices Market:
• Drug powder inhalers (DPIs) segment is projected to grow at a significant CAGR of 5.7% during the forecast period.
• North America was the leading region in 2015, and is expected to continue its dominance throughout the analysis period.
• The COPD and asthma devices market in Europe is projected to grow at a CAGR of 6.1%.
• The compressor nebulizers segment is expected to register a CAGR of 5.4%.

Send Enquiry on this report @
www.alliedmarketresearch.com/purchase-enquiry/579?utm_source=PC_OPR

About Us:

Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1?855?550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release COPD and Asthma Devices Market: High-end Analysis of the Key Segments with Leading Manufacturers like Novartis AG, Merck & Co., Inc., AstraZeneca Plc, Philips Healthcare and 3M Health Care here

News-ID: 1596919 • Views: 623

More Releases from Allied Market

Anaerobic Adhesives Market How Top Companies Adapted after COVID-19 Hit Its Busi …
Allied Market Research published a new report, titled, Anaerobic Adhesives Market: Global Opportunity Analysis and Industry Forecast, 2020–2027” The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter’s Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and determine steps to be taken to
Hybrid Fabrics Market is Booming Worldwide at a CAGR of 9.0% from 2020 to 2027
Allied Market Research published a report, titled, "Hybrid Fabrics Market by Fiber Type (Glass/Carbon, Carbon/Uhmwpe, Glass/Aramid, Carbon/Aramid, and Others) and Application (Automotive, Aerospace & Defense, Wind Energy, Sports & Recreational Equipment, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027" According to the report published by Allied Market Research, the global hybrid fabrics market garnered $213.4 million in 2019, and is projected to reach $418.0 million by 2027, growing at
Metal Removal Fluids Market: Recent Study Including Key Players, Applications, G …
Allied Market Research published a new report, titled, " Metal Removal Fluids Market: Growth Opportunity Analysis and Industry Forecast, 2019–2027." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter’s Five Forces analysis, and competitive lan dscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and determine steps
World Chromatography Reagents Market In-Depth Analysis Of Current Research, Grow …
According to a new report published by Allied Market Research, titled World Chromatography Reagents Market - Opportunities and Forecasts, 2020-2027 The global market size Chromatography Reagents is $XX million in 2019 with XX CAGR, and it is expected to reach $XX million by the end of 2027 with a CAGR of XX% from 2020 to 2027. The key players of the market are Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Dani Instruments S.P.A.,

All 5 Releases


More Releases for COPD

COPD Therapeutics Global Market Research Report 2019
COPD Therapeutics Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-medical-devices/copd-therapeutics-market/80858 The report firstly introduced the COPD Therapeutics basics: definitions, classifications, applications and market
Asthma and COPD Drugs Market worth $50,359 Million by 2022
"The key players of the Global COPD and asthma drugs market are employing novel concepts and ideas to improve, manage and control asthma & COPD, and also enhance their profitability so as to gain a competitive edge over the other market players. Seretide/Advair, Symbicort, and Singular were leading brands and accounted for around one-fourth share in world COPD and asthma drugs market." Global Asthma and COPD Drugs Market was valued at
Alarming Prevalence of COPD to Propel Oxygen Therapy Devices Market
"Oxygen therapy equipment market driven by increasing urbanization and rising levels of air pollution." An intelligence report on the global oxygen therapy equipment market has been added to the burgeoning portfolio of MarketResearchReports.biz. Titled, “Global Oxygen Therapy Equipment Market - Analysis By Product, Portability, Application, Region, Country: Opportunities and Forecast (2017- 2022) - By Product (Oxygen Concentrators, Liquid Oxygen Devices and Oxygen Cylinders), By Portability (Stationary, Portable Devices), By Application (COPD,
Asthma and COPD Drugs Market | Key Opportunities And Forecast 2024
The top five companies in the U.S. and China Asthma And Copd Drugs Market accounted for just under 64.0% in 2015, hinting at not just the consolidated nature of this industry but also at the immense competition among players. GlaxoSmithKline plc, Astrazeneca plc, Boehringer Ingelheim, Merck & Co. Inc., and Novartis AG currently enjoy the leading spots in the asthma and COPD drugs market. According to Transparency Market Research, the opportunity
Global COPD and Asthma Devices Market Size
According to a new report, Global COPD and Asthma Devices Market, published by KBV Research, The Global COPD and Asthma Devices Market attained a market size of $ 27,465.1 Million in 2015 and is expected to reach $ 39,051.4 Million by 2022 growing at a CAGR of 5.2 % CAGR during 2016 – 2022. The Asia Pacific market dominated the Global COPD and Asthma Devices Market in 2015 and would
COPD Drug Market Opportunity & Clinical Pipeline Analysis
Close to 1 Billion people worldwide suffer from respiratory or pulmonary diseases. In the respiratory therapeutic domain, Asthma and COPD are the major categories, accounting for close to 75% of the total patient for respiratory or pulmonary diseases. Chronic obstructive pulmonary disease (COPD) is a disease which progresses in the lungs and requires treatment all through the life. It is an inflammatory disorder which is characterized by obstruction in the